GEneroso pharmaceutical &Chemicals Inc. Background of the Study: The Generoso Pharmaceutical and Chemicals Inc.‚ was once a family merchandising business and is now one of the emerging pharmaceutical companies in the Philippines. Due to its increase volumes of operation GPC was incorporated in the year 1982 and by the help of its treasurer and comptroller‚ Elizabeth Generoso segregates control over GPC’s different product lines and‚ thus‚ initiated the reorganization of GPC by 1988. In its
Premium Pharmacology Pharmaceutical drug Pharmacy
INDIAN PHARMACEUTICAL INDUSTRY: A VISION WITH ITS STRENGTH AND WEAKNESS Dr. A. SELVARAJ* ABSTRACT The future of Indian pharmaceutical sector looks extremely positive. Indian pharma companies are vying for the branded generic drug space to register their global presence. Several Indian pharmaceutical companies have acquired companies in the US and Europe and many others are raising funds to do so. The Indian Pharmaceutical industry
Premium Pharmaceutical industry Pharmacology Generic drug
candidates that can be further developed. Pharmaceutical companies often have relevant compounds that have not been assessed for their potential to treat colorectal cancer. The overall objective for this company‚ Arias Pharmaceuticals‚ is to help and support the discovery of new drug leads for colorectal cancer through networks and partnerships between pharmaceutical companies as well as academia. Specifically‚ the
Premium Colorectal cancer Cancer Drug discovery
Control Ordinance - 1982. The recent developments of this sector has enabled Bangladesh to export medicines to global markets including the European market. This sector is also providing 95 per cent of the total medicine requirement of the local market. Pharma leaders in the country are beefing up their business activities with the aim to expand export market. Recently a few new industries have also been established with hi-tech equipment and professionals which will enhance the strength of this sector
Free Pharmacology Pharmacy Drug
Case 34 Lorex Pharmaceuticals Elaina Wesel MANA 6302 N1 Abstract This report will seek to outline and discuss the challenges faced by Lorex Pharmaceuticals. This report will detail the circumstances that dictated the challenge faced Lorex Pharmaceuticals‚ as well as the key areas they must consider when attempting to resolve this challenge. The report will examine the possible outcomes‚ and make a final recommendation based on the information provided. When developing a brand new product
Premium Marketing Pharmacology Management
1.1 OVERVIEW: Trade Related Aspects of Intellectual property Rights was put into effect in the developed countries since Jan 1996. And it will be implemented in Less Developed Countries starting from Jan 2006. Egypt is preparing its pharmaceutical industry for such agreement. A sense of optimism is expressed in the rich North. While a sense of pessimism is expressed in the poor South. Research and Development companies feel quite secure. Reverse Engineering companies (producing imitated products)
Premium Patent
------------------------------------------------- Fundamental Analysis Fundamental analysis is a technique that attempts to determine a security’s value by focusing on underlying factors that affect a company ’s actual business and its future prospects. On a broader scope‚ you can perform fundamental analysis on industries or the economy as a whole. The term simply refers to the analysis of the economic well-being of a financial entity as opposed to only its price movements. Fundamental analysis serves to answer questions‚ such
Premium Generic drug Pharmaceutical industry Financial ratios
IBUS 3312 - International Management Pharmaceutical Companies‚ Intellectual Property‚ and the Global AIDS Epidemic Analysis While this case is literally full of negative aspects‚ we will only focus on the main points for both arguments. Pharmaceutical companies want to be sure that the products they spend years and millions of dollars to create are not easily reproduced and sold at discount prices. The profits pharmaceuticals make of their patented products are supposed to refinance
Premium United Nations AIDS Developing country
publishes report on “The Global Cybersecurity Market 2013-2023”. This report is the result of SDI’s extensive market and company research covering the global cyber security industry. It provides detailed analysis of both historic and forecast global industry values‚ factors influencing demand‚ the challenges faced by industry participants‚ analysis of the leading companies in the industry‚ and key news. Introduction and Landscape Why was the report written? "The Global Cybersecurity Market 2013-2023"
Premium Computer security Security Information security
Global Case Study Analysis Scarlett Halifax Marketing Research/MKT 441 Shelli Boydstun September 30‚ 2013 1. Conduct a SWOT analysis of S/M (4-6 bullet points in each category) Strengths: Awarding winning Longevity Ability to adapt Loyalty of employees Weaknesses: The foreign customers Loyal employees Opportunities: Walk in customer Small towns Threats: Competitors Shifting standards Shifting population Lost of credilcials 2. What types of information will Brooks need to collect
Premium Assessment Marketing Market research